Logo image of NSPR

INSPIREMD INC (NSPR) Stock Fundamental Analysis

NASDAQ:NSPR - Nasdaq - US45779A8466 - Common Stock - Currency: USD

2.55  -0.05 (-1.92%)

Fundamental Rating

3

NSPR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 191 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for NSPR as it has an excellent financial health rating, but there are worries on the profitability. NSPR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NSPR has reported negative net income.
In the past year NSPR has reported a negative cash flow from operations.
In the past 5 years NSPR always reported negative net income.
In the past 5 years NSPR always reported negative operating cash flow.
NSPR Yearly Net Income VS EBIT VS OCF VS FCFNSPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -68.38%, NSPR is doing worse than 73.30% of the companies in the same industry.
NSPR's Return On Equity of -88.69% is on the low side compared to the rest of the industry. NSPR is outperformed by 61.26% of its industry peers.
Industry RankSector Rank
ROA -68.38%
ROE -88.69%
ROIC N/A
ROA(3y)-61.73%
ROA(5y)-56.41%
ROE(3y)-81.81%
ROE(5y)-75.32%
ROIC(3y)N/A
ROIC(5y)N/A
NSPR Yearly ROA, ROE, ROICNSPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600 800

1.3 Margins

NSPR has a Gross Margin of 21.49%. This is in the lower half of the industry: NSPR underperforms 78.53% of its industry peers.
NSPR's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for NSPR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.84%
GM growth 5Y1.01%
NSPR Yearly Profit, Operating, Gross MarginsNSPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

7

2. Health

2.1 Basic Checks

NSPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NSPR has been increased compared to 1 year ago.
NSPR has more shares outstanding than it did 5 years ago.
There is no outstanding debt for NSPR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NSPR Yearly Shares OutstandingNSPR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NSPR Yearly Total Debt VS Total AssetsNSPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -4.49, we must say that NSPR is in the distress zone and has some risk of bankruptcy.
NSPR has a worse Altman-Z score (-4.49) than 64.40% of its industry peers.
There is no outstanding debt for NSPR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.49
ROIC/WACCN/A
WACC9.03%
NSPR Yearly LT Debt VS Equity VS FCFNSPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

NSPR has a Current Ratio of 5.28. This indicates that NSPR is financially healthy and has no problem in meeting its short term obligations.
NSPR has a better Current ratio (5.28) than 77.49% of its industry peers.
A Quick Ratio of 4.94 indicates that NSPR has no problem at all paying its short term obligations.
NSPR has a better Quick ratio (4.94) than 80.63% of its industry peers.
Industry RankSector Rank
Current Ratio 5.28
Quick Ratio 4.94
NSPR Yearly Current Assets VS Current LiabilitesNSPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

6

3. Growth

3.1 Past

NSPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.78%, which is quite impressive.
The Revenue has grown by 12.92% in the past year. This is quite good.
Measured over the past years, NSPR shows a quite strong growth in Revenue. The Revenue has been growing by 13.51% on average per year.
EPS 1Y (TTM)27.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.75%
Revenue 1Y (TTM)12.92%
Revenue growth 3Y15.92%
Revenue growth 5Y13.51%
Sales Q2Q%10.68%

3.2 Future

NSPR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.22% yearly.
Based on estimates for the next years, NSPR will show a very strong growth in Revenue. The Revenue will grow by 91.28% on average per year.
EPS Next Y-17.04%
EPS Next 2Y1.28%
EPS Next 3Y14.22%
EPS Next 5YN/A
Revenue Next Year28.48%
Revenue Next 2Y87%
Revenue Next 3Y91.28%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NSPR Yearly Revenue VS EstimatesNSPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
NSPR Yearly EPS VS EstimatesNSPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 2026 2027 -1M -2M -3M -4M -5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NSPR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NSPR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NSPR Price Earnings VS Forward Price EarningsNSPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NSPR Per share dataNSPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

NSPR's earnings are expected to grow with 14.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.28%
EPS Next 3Y14.22%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NSPR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INSPIREMD INC

NASDAQ:NSPR (4/22/2025, 4:33:14 PM)

2.55

-0.05 (-1.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-12 2025-03-12/bmo
Earnings (Next)05-12 2025-05-12/bmo
Inst Owners40.55%
Inst Owner Change0.24%
Ins Owners20.74%
Ins Owner Change11.72%
Market Cap78.13M
Analysts82.5
Price Target4.85 (90.2%)
Short Float %1.14%
Short Ratio3.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.02%
Min EPS beat(2)4.47%
Max EPS beat(2)21.57%
EPS beat(4)2
Avg EPS beat(4)-6.18%
Min EPS beat(4)-37.25%
Max EPS beat(4)21.57%
EPS beat(8)6
Avg EPS beat(8)5.64%
EPS beat(12)10
Avg EPS beat(12)12.34%
EPS beat(16)14
Avg EPS beat(16)16.25%
Revenue beat(2)2
Avg Revenue beat(2)3.58%
Min Revenue beat(2)1.97%
Max Revenue beat(2)5.18%
Revenue beat(4)3
Avg Revenue beat(4)3.03%
Min Revenue beat(4)-2.03%
Max Revenue beat(4)7.01%
Revenue beat(8)7
Avg Revenue beat(8)5.89%
Revenue beat(12)10
Avg Revenue beat(12)4.66%
Revenue beat(16)12
Avg Revenue beat(16)3.13%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)38.46%
EPS NQ rev (3m)-42.86%
EPS NY rev (1m)35.14%
EPS NY rev (3m)35.14%
Revenue NQ rev (1m)-6.45%
Revenue NQ rev (3m)-22.77%
Revenue NY rev (1m)-14.15%
Revenue NY rev (3m)-14.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.15
P/FCF N/A
P/OCF N/A
P/B 2.17
P/tB 2.17
EV/EBITDA N/A
EPS(TTM)-0.78
EYN/A
EPS(NY)-0.91
Fwd EYN/A
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)-0.71
OCFYN/A
SpS0.23
BVpS1.18
TBVpS1.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -68.38%
ROE -88.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.49%
FCFM N/A
ROA(3y)-61.73%
ROA(5y)-56.41%
ROE(3y)-81.81%
ROE(5y)-75.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.84%
GM growth 5Y1.01%
F-Score3
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 500.71%
Cap/Sales 20%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.28
Quick Ratio 4.94
Altman-Z -4.49
F-Score3
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)304.1%
Cap/Depr(5y)236.96%
Cap/Sales(3y)11.74%
Cap/Sales(5y)9.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.75%
EPS Next Y-17.04%
EPS Next 2Y1.28%
EPS Next 3Y14.22%
EPS Next 5YN/A
Revenue 1Y (TTM)12.92%
Revenue growth 3Y15.92%
Revenue growth 5Y13.51%
Sales Q2Q%10.68%
Revenue Next Year28.48%
Revenue Next 2Y87%
Revenue Next 3Y91.28%
Revenue Next 5YN/A
EBIT growth 1Y-58.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-27.7%
EBIT Next 3Y2.05%
EBIT Next 5YN/A
FCF growth 1Y-38.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.54%
OCF growth 3YN/A
OCF growth 5YN/A